Oric Pharmaceuticals, Inc.

ORIC

Oric Pharmaceuticals, Inc.

ORIC

Insider Sentiment (TTM):

Last Purchase:2025-06-23Last Sale:2026-02-24Shares Purchased (TTM):0Shares Sold (TTM):336,776

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:112,895,470Shares Outstanding:105,472,766Institutional Ownership Pct.:107.04%

Earnings Market Reaction:

Filing Date:2026-08-03Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	37	56	46	50	76	49	59	44	50	56	23	26
Available For Sale Securities Debt Securities Curr…	227	226	236	237	207	154	197	228	237	260	185	201
Prepaid Expense And Other Assets Current	9	8	7	8	9	8	6	7	8	7	4	5
Assets Current	274	290	288	296	291	211	262	279	295	324	213	232
Available For Sale Securities Debt Securities Nonc…	123	138	111	126	45	20	0	10	22	15	27	29
Property Plant And Equipment Net	2	2	2	3	3	3	3	3	3	3	3	3
Other Assets Noncurrent	6	7	7	7	8	8	9	10	9	9	10	10
Assets	405	437	409	431	347	243	274	302	329	351	252	274
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	4	3	4	3	3	5	2	4	2	3	1	4
Accrued Liabilities Current	17	15	17	17	15	12	23	17	17	12	20	15
Liabilities Current	21	18	20	20	18	18	25	21	20	15	20	19
Other Liabilities Noncurrent	3	3	4	4	5	6	6	7	7	7	7	8
Liabilities	23	21	25	24	23	23	31	28	27	22	28	27
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	1,152	1,144	1,076	1,068	953	812	806	800	795	789	659	654
Retained Earnings Accumulated Deficit	-770	-728	-692	-662	-629	-593	-563	-526	-492	-460	-435	-407
Accumulated Other Comprehensive Income Loss Net Of…	-1	-0	1	1	0	0	0	1	-0	-0	0	-0
Stockholders Equity	381	416	384	407	324	220	243	274	302	329	224	247
Liabilities And Stockholders Equity	405	437	409	431	347	243	274	302	329	351	252	274
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	200	200	200	200	200	200	200	200	200	200	200	200
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Common Stock Shares Issued	104	103	99	97	86	71	71	71	68	67	55	55
Shares Outstanding	104	103	99	97	86	71	71	71	68	67	55	55

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-12.25%	-1.04%	25.65%	-	-	-	-	-	-	-	-	-
2025	43.33%	80.88%	100.70%	14.29%	21.48%	38.24%	-9.76%	-32.98%	-15.83%	-4.70%	-8.20%	-30.40%
2024	-4.06%	-24.55%	27.00%	16.55%	16.06%	13.65%	-3.51%	-16.67%	1.56%	-0.76%	-37.32%	-35.29%
2023	-	-	-	17.02%	-23.71%	-20.81%	19.86%	33.33%	47.97%	-26.82%	-35.22%	-40.03%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	13.19	16.33	14.13	14.65	16.13	12.00	10.56	13.15	15.08	21.31	10.39	12.26
Quick Ratio	12.76	15.86	13.79	14.23	15.65	11.56	10.30	12.82	14.66	20.83	10.18	12.00
Working Capital	252.94M	272.46M	268.05M	275.42M	273.07M	193.82M	237.40M	258.18M	275.06M	308.87M	192.14M	213.29M
Leverage & Debt
Debt to Equity	0.06	0.05	0.06	0.06	0.07	0.11	0.13	0.10	0.09	0.07	0.12	0.11
Interest Coverage TTM	-	-	-	-	-	-	-	-	-	-	-63.92	-33.77
Debt Ratio	0.06	0.05	0.06	0.06	0.07	0.10	0.11	0.09	0.08	0.06	0.11	0.10
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.30	-1.28	-1.47	-1.37	-1.76	-1.87	-1.83	-1.70	-1.57	-1.51	-1.96	-1.62
Free Cash Flow Per Share TTM	-1.04	-1.06	-1.28	-0.86	-1.14	-1.64	-1.63	-1.56	-1.43	-1.43	-1.68	-1.36
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	2.26%	1.77%	1.27%	12.85%	23.89%	30.56%	26.96%	28.60%	19.68%	13.19%	12.99%	2.38%
EPS Growth (1Y)	-26.03%	-31.45%	-19.57%	-19.55%	11.56%	23.77%	-6.32%	4.64%	-22.33%	-24.22%	-12.92%	-29.41%
Valuation Metrics
P/E TTM	-8.33	-9.88	-5.55	-8.78	-5.78	-2.98	-4.40	-6.03	-4.49	-9.10	-4.70	-3.73
P/B TTM	3.07	3.22	1.87	2.92	2.45	1.80	2.31	2.64	1.64	2.82	2.11	1.40
Market Cap	1.17B	1.34B	718.15M	1.19B	792.98M	396.41M	562.70M	723.06M	497.36M	926.06M	473.35M	347.28M
Enterprise Value	1.13B	1.28B	671.99M	1.14B	716.63M	346.58M	502.81M	678.34M	447.04M	869.21M	449.47M	320.55M
Calculated Values
Free Cash Flow TTM	-112.74M	-111.85M	-112.33M	-84.97M	-89.04M	-116.37M	-113.85M	-109.90M	-100.41M	-96.00M	-86.54M	-77.83M
Net Debt	-37.48M	-56.89M	-46.16M	-50.16M	-76.36M	-49.83M	-59.90M	-44.72M	-50.32M	-56.85M	-23.88M	-26.73M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-24Sale

Owner: Piscitelli, Dominic

Title: Chief Financial Officer

Shares: 52,000

Price/Share: $13.51

Value: $702,520.00

Shares Owned: 68,148

Relationship: Officer

Ownership: Direct

2026-01-16Sale

Owner: Heyman, Richard A.

Title: -

Shares: 3,500

Price/Share: $12.00

Value: $42,000.00

Shares Owned: 41,800

Relationship: Director

Ownership: Direct

2025-12-16Sale

Owner: Multani, Pratik S

Title: Chief Medical Officer

Shares: 10,720

Price/Share: $9.06

Value: $97,123.20

Shares Owned: 68,149

Relationship: Officer

Ownership: Direct

2025-12-16Sale

Owner: Chacko, Jacob

Title: PRESIDENT AND CEO

Shares: 33,374

Price/Share: $9.06

Value: $302,368.44

Shares Owned: 581,711

Relationship: Director,Officer

Ownership: Direct

2025-12-16Sale

Owner: Piscitelli, Dominic

Title: Chief Financial Officer

Shares: 10,720

Price/Share: $9.06

Value: $97,123.20

Shares Owned: 68,148

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-24	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	52,000	13.51	$702,520.00	68,148	4
2026-01-16	Heyman, Richard A.	Director	-	Direct	Sale	3,500	12.00	$42,000.00	41,800	4
2025-12-16	Multani, Pratik S	Officer	Chief Medical Officer	Direct	Sale	10,720	9.06	$97,123.20	68,149	4
2025-12-16	Chacko, Jacob	Director,Officer	PRESIDENT AND CEO	Direct	Sale	33,374	9.06	$302,368.44	581,711	4
2025-12-16	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	10,720	9.06	$97,123.20	68,148	4
2025-10-06	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	11,000	14.52	$159,720.00	48,317	4
2025-10-06	Chacko, Jacob	Director,Officer	PRESIDENT AND CEO	Direct	Sale	37,461	12.32	$461,519.52	531,419	4
2025-10-01	Chacko, Jacob	Director,Officer	PRESIDENT AND CEO	Direct	Sale	53,001	12.05	$638,662.05	568,880	4
2025-09-22	Chacko, Jacob	Director,Officer	PRESIDENT AND CEO	Direct	Sale	125,000	10.80	$1,350,000.00	656,419	4
2025-07-01	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	20,000	10.05	$201,000.00	48,317	4
2025-06-24	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	32,466	10.50	$340,893.00	68,317	4
2025-06-23	You, Angie	Director	-	Direct	Purchase	1,403	9.43	$13,230.29	28,000	4
2025-06-12	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	300	10.00	$3,000.00	101,817	4
2025-06-11	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	2,976	10.00	$29,760.00	102,117	4
2025-06-09	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	300	10.00	$3,000.00	103,864	4
2024-12-16	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	8,851	8.28	$73,286.28	106,764	4
2024-12-16	Multani, Pratik S	Officer	Chief Medical Officer	Direct	Sale	8,850	8.28	$73,278.00	46,765	4
2024-12-16	Chacko, Jacob	Director,Officer	PRESIDENT AND CEO	Direct	Sale	24,660	8.28	$204,184.80	778,648	4
2024-03-06	Chacko, Jacob	Director,Officer	PRESIDENT AND CEO	Direct	Sale	40,000	16.21	$648,400.00	728,544	4
2024-02-07	Chacko, Jacob	Director,Officer	PRESIDENT AND CEO	Direct	Sale	26,042	12.30	$320,316.60	768,544	4
2023-12-15	Piscitelli, Dominic	Officer	Chief Financial Officer	Direct	Sale	5,282	8.58	$45,319.56	83,809	4
2023-12-15	Multani, Pratik S	Officer	Chief Medical Officer	Direct	Sale	5,282	8.59	$45,372.38	23,809	4
2023-12-15	Chacko, Jacob	Director,Officer	President and CEO	Direct	Sale	14,539	8.58	$124,744.62	808,544	4
2023-07-11	Chacko, Jacob	Director,Officer	President and CEO	Direct	Sale	5,156	8.01	$41,299.56	780,652	4
2023-07-05	Chacko, Jacob	Director,Officer	President and CEO	Direct	Sale	4,336	8.01	$34,731.36	796,316	4
2023-06-26	Chacko, Jacob	Director,Officer	President and CEO	Direct	Sale	20,000	8.03	$160,600.00	800,652	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

107.04%

Inst. Shares: 112,895,470

Shares Outstanding: 105,472,766

2025-12-31

131.70%

Inst. Shares: 115,621,809

Shares Outstanding: 87,793,801

2025-09-30

104.59%

Inst. Shares: 103,497,521

Shares Outstanding: 98,953,331

2025-06-30

115.52%

Inst. Shares: 90,252,122

Shares Outstanding: 78,126,257

2025-03-31

109.29%

Inst. Shares: 77,643,713

Shares Outstanding: 71,040,580

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	112,895,470	105,472,766	107.04%
2025-12-31	115,621,809	87,793,801	131.70%
2025-09-30	103,497,521	98,953,331	104.59%
2025-06-30	90,252,122	78,126,257	115.52%
2025-03-31	77,643,713	71,040,580	109.29%
2024-12-31	74,260,235	69,727,940	106.50%
2024-09-30	68,499,775	70,542,684	97.10%
2024-06-30	66,282,041	70,348,414	94.22%
2024-03-31	62,015,850	67,349,551	92.08%
2023-12-31	49,651,758	51,450,848	96.50%
2023-09-30	47,460,784	57,402,226	82.68%
2023-06-30	42,984,787	45,654,208	94.15%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Oric Pharmaceuticals, Inc. (ORIC) — SEC Financial Statements & Analysis

Oric Pharmaceuticals, Inc. (ORIC) is a pharmaceutical preparations company, incorporated in DE. Oric Pharmaceuticals, Inc. trades on Nasdaq as: ORIC. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Oric Pharmaceuticals, Inc. reported a Debt-to-Equity ratio of 0.06x, a Price-to-Book (P/B) ratio of 3.07x (TTM), at a market cap of $1.17B. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.06x
P/B TTM: 3.07x
Market Cap: $1.17B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Oric Pharmaceuticals, Inc. in?

Oric Pharmaceuticals, Inc. (ORIC) operates in the Pharmaceutical Preparations industry.

What is ORIC's market cap?

Oric Pharmaceuticals, Inc. (ORIC) has a market capitalization of $1.17B as of 2026-06-30.

What exchange does ORIC trade on?

Oric Pharmaceuticals, Inc. (ORIC) trades on the Nasdaq.

Where is Oric Pharmaceuticals, Inc. incorporated?

Oric Pharmaceuticals, Inc. is incorporated in DE.